LoadingLoadingLoadingThe quick read
Latest quote·Oct 7
Net buying: insiders sold $0 and bought $177K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNet buying: insiders sold $0 and bought $177K of OPAL stock on the open market in the 90 days to Oct 13, 2026, according to SEC Form 4 filings. The largest was Comora, Adam (Co-Chief Executive Officer), who bought $138K. The latest filing was on Sep 8, 2026.
None. No member of Congress disclosed a OPAL trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
This summary uses filings available on Oct 13, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position and insiders have been net buying.
No tracked top-trader positions in OPAL right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Aug 6, 2026
Period ending
Jun 30, 2026
Earnings per share
$0.19 expected
Revenue
No reported revenue on record
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | -$0.05 / $0.19Alpha Vantage | -126.32% miss | Unavailable | Unavailable |
| Mar 31, 2026 | May 11, 2026 | $0.15 / $0.05Alpha Vantage | +$0.10 beat | Unavailable | Unavailable |
| Dec 31, 2025 | Mar 16, 2026 | $0.20 / $0.16Alpha Vantage | +22.40% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 6, 2025 | -$0.10 / $0.14Alpha Vantage | -$0.24 miss | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 7, 2025 | $0.03 / $0.13Alpha Vantage | -76.92% miss | Unavailable | Unavailable |
| Mar 31, 2025 | May 8, 2025 | $0.24 / $0.11Alpha Vantage | +118.18% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Mar 13, 2025 | -$0.05 / $0.18Alpha Vantage | -127.78% miss | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 8, 2024 | $0.24 / $0.16Alpha Vantage | +50.00% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $83.4M | $99.8M | $73.4M | $82.6M |
| Cost of what it sold | $57.9M | $69.2M | $53.8M | $64.1M |
| Gross profit | $25.4M | $30.6M | $19.5M | $18.5M |
| What it spent | ||||
| Research and development | — | $2.8M | $1.8M | — |
| Sales and admin | $14.4M | $16.2M | $15.2M | $14.3M |
| Other operating costs | $8.1M | $5.7M | $5.6M | $3.3M |
| Total operating expenses | $22.5M | $24.7M | $22.6M | $17.6M |
| What was left | ||||
| Operating profit | $3.0M | $5.8M | -$3.1M | $954.0K |
| Interest on debt | $7.2M | $7.3M | $6.6M | $8.6M |
| Profit before tax | -$3.2M | -$274.0K | -$11.3M | -$8.9M |
| Tax | -$14.6M | -$16.5M | -$5.7M | -$4.7M |
| Net profit | $4.1M | $4.9M | $6.9M | $2.9M |
| EBITDA | $9.2M | $15.8M | $955.0K | $6.1M |
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
